What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline? Source: ERS Research Seminar 2016 Year: 2016
Occupational COPD : what is new and how do we identify and ultimately prevent this disease? Source: International Congress 2019 – PG13 Traditional and modern clinical approaches for diagnosis and management of occupational airways diseases Year: 2019
COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
The future of COPD treatment: what are the difficulties in and barriers to drug development for COPD Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD Year: 2011
How to manage a patient with COPD - early identification and how to prevent progression Source: ERS Satellites 2021 Year: 2021
Who should receive which biologic and why? Current and future approaches in severe asthma patients Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what? Year: 2021
What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis Source: Eur Respir Monogr 2018; 82: 414-429 Year: 2018
Rethinking the way we are treating established airway disease: current guidelines need to change Source: International Congress 2016 – Presentation and discussion of a draft Lancet Commission on Asthma Year: 2016
What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018
A survey of the multidisciplinary team‘s knowledge of the management of patients with COPD, in order to help identify future training needs Source: Annual Congress 2009 - Medical education Year: 2009
Using population insight studies to define effective prevention and identification interventions in COPD Source: Annual Congress 2011 - Quality of diagnosis and assessment in primary care Year: 2011
Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
The paradoxes of asthma management: time for a new approach? Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017 Year: 2017
Barriers to new drug development in respiratory disease Source: Eur Respir J 2015; 45: 1197-1207 Year: 2015
Barriers to new drug development in respiratory disease Source: Eur Respir J 2016; 47: 356-357 Year: 2016
The concept of control in COPD: a new proposal for optimising therapy Source: Eur Respir J 2014; 44: 1072-1075 Year: 2014
Which are the best methods to manage COPD patients in the post-COVID era? Source: Virtual Congress 2021 – Part I: restarting COPD care in the post-COVID era Year: 2021